Clustering analysis using the 5,000 most variable probes highlighted relevant breast cancer phenotypes: ER+, PR+, HER2+ and triple-negative tumours (Figure 2 andAdditional file 7). This evidence concerns the gene ERBB2 and breast carcinoma.